PCOS [2026]: The Complete Honest Guide

Polycystic ovary syndrome (PCOS) affects an estimated 8-13% of women of reproductive age globally, making it one of the most common endocrine disorders in women. It is also significantly underdiagnosed — studies suggest that up to 70% of affected women have not received a diagnosis. Understanding what PCOS actually is, what the diagnostic criteria mean, and what the evidence shows about management is worth the effort for anyone who has or suspects PCOS.

What PCOS Actually Is

PCOS is a hormonal and metabolic condition characterized by a combination of features: elevated androgens (male hormones such as testosterone), irregular or absent menstrual cycles, and polycystic ovaries on ultrasound. Crucially, PCOS is not caused by the ovarian cysts — the cysts are a consequence of disrupted follicle development, not the cause of the syndrome. The name is something of a misnomer.

The hormonal imbalance in PCOS is complex and varies between individuals. Elevated insulin levels (insulin resistance is common in PCOS even in women without obesity) stimulate the ovaries to produce excess androgens. Elevated androgens disrupt the normal follicle development cycle, preventing regular ovulation. The resulting irregular or absent ovulation produces menstrual irregularity and, in many cases, reduced fertility. The connection between insulin resistance and PCOS explains why lifestyle interventions affecting insulin sensitivity (diet, exercise, weight management) can improve PCOS symptoms.

The Diagnostic Criteria

PCOS is diagnosed using the Rotterdam Criteria (2003), which requires at least two of three features: oligo- or anovulation (irregular or absent ovulation, evidenced by irregular periods), clinical or biochemical signs of hyperandrogenism (elevated testosterone or related hormones, or physical signs including hirsutism, acne, or male-pattern hair loss), and polycystic ovarian morphology on ultrasound (12+ follicles in one or both ovaries, or increased ovarian volume).

The diagnostic requirement of only two of three features means that PCOS presents differently in different individuals. Some women with PCOS have all three features; others have irregular periods and elevated androgens without polycystic ovaries; others have polycystic ovaries and androgen excess with regular cycles. This phenotypic variability is one reason PCOS is underdiagnosed — presentations that don't match the textbook picture may not be recognized.

The Conditions That Commonly Accompany PCOS

PCOS is associated with several conditions that require separate attention. Insulin resistance and elevated metabolic risk — women with PCOS have significantly higher risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease than age-matched women without PCOS. This metabolic dimension makes PCOS a chronic health concern beyond its reproductive consequences.

Depression and anxiety occur at higher rates in women with PCOS than in the general population, with prevalence estimates 3-4 times higher. The relationship is bidirectional: PCOS symptoms (particularly hirsutism and acne, which affect appearance; irregular periods, which create uncertainty; and fertility concerns) affect mental health, and mental health conditions can affect PCOS management through effects on lifestyle factors.

Endometrial hyperplasia and endometrial cancer risk are elevated in women with PCOS because chronic anovulation means the endometrium isn't shed regularly. Women with PCOS who have infrequent periods are often advised to induce a period medically at least four times per year to reduce endometrial hyperplasia risk.

What the Evidence Shows About Management

Lifestyle intervention — specifically improvements in diet and exercise that improve insulin sensitivity — is the first-line treatment recommendation for PCOS in most clinical guidelines, particularly for women with metabolic concerns. The specific diet type matters less than adherence; both low-glycemic-index diets and Mediterranean diet patterns have evidence for improving PCOS-related metabolic markers. Even a 5-10% reduction in body weight in women with PCOS who are overweight can produce significant improvements in menstrual regularity and metabolic markers.

Metformin, an insulin-sensitizing medication used primarily in type 2 diabetes, is used off-label in PCOS for its effects on insulin resistance and associated metabolic and reproductive outcomes. Evidence supports its use for metabolic risk reduction and, in combination with other approaches, for improving ovulation in women with PCOS seeking pregnancy.

Combined oral contraceptive pills are commonly prescribed for cycle regulation and androgen-related symptoms (acne, hirsutism) in women with PCOS who are not trying to conceive. They do not treat the underlying condition but manage symptoms effectively and protect against endometrial hyperplasia.

Honest Bottom Line: PCOS affects approximately 10% of women of reproductive age and is significantly underdiagnosed because of phenotypic variability — not everyone presents with all three diagnostic features. The condition is metabolic as much as reproductive: insulin resistance, elevated diabetes and cardiovascular risk, and mental health consequences require attention alongside the reproductive symptoms. Lifestyle intervention improving insulin sensitivity is the first-line treatment in most guidelines. Metformin addresses underlying insulin resistance. Oral contraceptives manage symptoms but don't treat the underlying condition.